Baseline model | β | p-value | Odds ratio | 95% CI | |
---|---|---|---|---|---|
Female gender | -0.572 | 0.018 | 0.56 | 0.35 | 0.91 |
Age bracket (years) | |||||
18-49* | 0.000 | ||||
50-59 | 0.961 | 0.011 | 2.61 | 1.25 | 5.47 |
60-69 | 1.359 | 0.000 | 3.89 | 1.93 | 7.85 |
70-79 | 1.388 | 0.000 | 4.01 | 1.97 | 8.13 |
80-99 | 2.102 | 0.000 | 8.18 | 3.54 | 18.90 |
Primary diagnosis (Charlson index ≥ 1) | 0.879 | 0.000 | 2.41 | 1.47 | 3.94 |
Secondary diagnoses (Charlson index) | |||||
0* | 0.009 | ||||
1 | 0.476 | 0.122 | 1.61 | 0.88 | 2.95 |
2 | 0.895 | 0.002 | 2.45 | 1.37 | 4.36 |
Urgency and emergency admissions | 1.750 | 0.000 | 5.76 | 3.12 | 10.61 |
Constant | -4.603 | 0.000 | 0.01 | ||
Final Model | β | p-value | Odds ratio | 95% CI | |
Female gender | -0.662 | 0.011 | 0.52 | 0.31 | 0.86 |
Age bracket (years) | |||||
18-49* | 0.000 | ||||
50-59 | 0.993 | 0.010 | 2.70 | 1.26 | 5.77 |
60-69 | 1.115 | 0.003 | 3.05 | 1.45 | 6.40 |
70-79 | 1.178 | 0.002 | 3.25 | 1.53 | 6.88 |
80-99 | 1.879 | 0.000 | 6.55 | 2.63 | 16.32 |
Primary diagnosis (Charlson index ≥ 1) | 0.859 | 0.001 | 2.36 | 1.40 | 3.98 |
Secondary diagnoses (Charlson index) | |||||
0* | 0.013 | ||||
1 | 0.523 | 0.107 | 1.69 | 0.89 | 3.18 |
2 | 0.893 | 0.004 | 2.44 | 1.33 | 4.49 |
Urgency and emergency admissions | 1.788 | 0.000 | 5.98 | 3.14 | 11.39 |
Length of stay | 0.008 | 0.044 | 1.01 | 1.00 | 1.02 |
Occurrence of adverse event | |||||
No* | |||||
Yes, non-preventable | 1.832 | 0.001 | 6.25 | 2.21 | 17.70 |
Yes, preventable | 2.108 | 0.000 | 8.23 | 4.02 | 16.82 |
Constant | -4.957 | 0.000 | 0.01 |